SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-23-032989
Filing Date
2023-11-24
Accepted
2023-11-24 16:30:08
Documents
4
Period of Report
2023-12-19

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A pbla20231124_def14a.htm DEF 14A 401193
2 pbla20231113_pre14aimg001.jpg GRAPHIC 4554
3 pcard01.jpg GRAPHIC 262321
4 pcard02.jpg GRAPHIC 256108
  Complete submission text file 0001437749-23-032989.txt   1122866
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39468 | Film No.: 231436982
SIC: 2834 Pharmaceutical Preparations